Company Profile

Auration Biotech Inc
Profile last edited on: 7/10/2024      CAGE: 8EW60      UEI: HA6KMH26H8U4

Business Identifier: Novel therapeutics for treatment of diseases of ear, nose and throat
Year Founded
2014
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1011 Hamilton Road Suite 300
Chapel Hill, NC 27517
   (984) 224-6031
   N/A
   www.aurationbiotech.com
Location: Single
Congr. District: 04
County: Orange

Public Profile

Disappointing absence of any in-depth (recent) information addressing the firms capabilities and history. Not even clear that a listing which would apear to be the firm identifies location of Auration Biotech, Inc., as based in San Mateo, California, - versus NIH listing in Chapel Hill NC - is a privately held biotechnology company dedicated to the development of novel therapeutics that restore or maintain hearing.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $200,240
Project Title: HB-EGF regeneration to treat oral aphthous ulcers

Key People / Management

  Benjamin Franklin McGraw III -- Chairman of Board

  Sanjay Chanda -- Co-Founder and Head of Drug Development

  Peter Santa Maria

Company News

There are no news available.